Project Number AARG-NTF-22-923774 Agency/Funding Organization Alzheimer's Association Funding Year 2022 View Full Project Details for Degrading BAZ2B as a new therapeutic strategy in Alzheimer’s disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) q. Epigenetic Regulators Researcher and Organization Principal Investigator Lolli, Graziano Principal Investigator Lolli, Graziano Awardee Organization University of Trento Awardee State N/A Contact PI Country Italy Project Detail Funding Opportunity Announcement AARG-NTF FY Overall Cost $125,500 Funding Organization Agency/Funding Organization Alzheimer's Association Funding Organization Country United States Program Official Alzheimer's Association
